Total Payments
$53,818
2024 Payments
$10,475
Companies
17
Transactions
110
Medicare Patients
366
Medicare Billing
$93,496
Payment Breakdown by Category
Consulting$32,848 (61.0%)
Travel$10,798 (20.1%)
Other$5,192 (9.6%)
Food & Beverage$4,981 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,848 | 10 | 61.0% |
| Travel and Lodging | $10,798 | 25 | 20.1% |
| Food and Beverage | $4,981 | 73 | 9.3% |
| Honoraria | $4,675 | 1 | 8.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $516.67 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $32,367 | 38 | $0 (2024) |
| H. Lundbeck A S | $7,347 | 7 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $5,027 | 19 | $0 (2024) |
| Indivior Inc. | $2,474 | 6 | $0 (2022) |
| Corcept Therapeutics | $2,250 | 2 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $1,876 | 15 | $0 (2024) |
| PFIZER INC. | $700.00 | 1 | $0 (2019) |
| Allergan, Inc. | $516.67 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $440.74 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $324.07 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,475 | 25 | Alkermes, Inc. ($9,857) |
| 2023 | $13,756 | 35 | H. Lundbeck A S ($7,347) |
| 2022 | $3,821 | 15 | Teva Pharmaceuticals USA, Inc. ($1,538) |
| 2021 | $2,094 | 3 | Alkermes, Inc. ($2,000) |
| 2020 | $5,263 | 9 | Indivior Inc. ($2,454) |
| 2019 | $10,736 | 17 | Alkermes, Inc. ($10,004) |
| 2017 | $7,673 | 6 | Alkermes, Inc. ($7,629) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Neurology | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $36.23 | General |
| Category: Neurology | ||||||
| 09/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Neurology | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Neurology | ||||||
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| 07/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $953.23 | General |
| Category: CNS | ||||||
| 07/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $601.92 | General |
| Category: CNS | ||||||
| 07/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $500.00 | General |
| Category: CNS | ||||||
| 07/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Neurology | ||||||
| 07/11/2024 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $36.64 | General |
| 06/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $45.95 | General |
| Category: Neurology | ||||||
| 06/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $49.15 | General |
| Category: Neuropsychiatry | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Neurology | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $127.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $37.41 | General |
| 05/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $42.31 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $56.43 | General |
| Category: CNS | ||||||
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $36.25 | General |
| Category: Psychiatry/Psychology | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $71.04 | General |
| 02/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Neurology | ||||||
| 01/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Consulting Fee | Cash or cash equivalent | $7,560.00 | General |
| Category: CNS | ||||||
| 01/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $132.97 | General |
| Category: CNS | ||||||
| 01/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $52.91 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 52 | 150 | $59,679 | $9,458 |
| 2022 | 3 | 71 | 325 | $127,524 | $22,763 |
| 2021 | 5 | 118 | 385 | $131,248 | $27,201 |
| 2020 | 5 | 125 | 531 | $174,757 | $34,074 |
Total Patients
366
Total Services
1,391
Medicare Billing
$93,496
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 57 | $38,604 | $5,736 | 14.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 18 | 51 | $17,429 | $2,801 | 16.1% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 15 | 42 | $3,646 | $920.45 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 121 | $86,320 | $13,968 | 16.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 24 | 114 | $36,456 | $6,918 | 19.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 22 | 90 | $4,748 | $1,877 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 97 | $69,064 | $11,809 | 17.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 103 | $25,132 | $6,774 | 27.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 22 | 90 | $27,360 | $5,482 | 20.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 22 | 81 | $4,050 | $1,735 | 42.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 14 | 14 | $5,642 | $1,401 | 24.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 200 | $48,800 | $13,400 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 111 | $83,221 | $10,778 | 13.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 22 | 108 | $32,900 | $6,554 | 19.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 21 | 100 | $5,000 | $2,123 | 42.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 12 | $4,836 | $1,219 | 25.2% |
About Dr. Jacob Ballon, MD
Dr. Jacob Ballon, MD is a Psychiatry healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083835474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Ballon, MD has received a total of $53,818 in payments from pharmaceutical and medical device companies, with $10,475 received in 2024. These payments were reported across 110 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($32,848).
As a Medicare-enrolled provider, Ballon has provided services to 366 Medicare beneficiaries, totaling 1,391 services with total Medicare billing of $93,496. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Palo Alto, CA
- Active Since 05/01/2007
- Last Updated 04/29/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1083835474
Products in Payments
- LYBALVI (Drug) $11,191
- Aristada 441 mg (Drug) $7,629
- ABILIFY MAINTENA (Drug) $7,347
- PERSERIS (Drug) $2,474
- Korlym (Drug) $2,250
- CELEBREX (Drug) $700.00
- UZEDY (Drug) $273.85
- ARISTADA (Drug) $233.73
- VRAYLAR (Drug) $183.92
- INGREZZA (Drug) $136.47
- CAPLYTA (Drug) $123.94
- NUPLAZID (Drug) $63.59
- REXULTI (Drug) $43.57
- COBENFY (Drug) $36.25
- AUSTEDO (Drug) $27.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Palo Alto
Dr. Julie Bonner, M.d, M.D
Psychiatry — Payments: $341,990
Psychiatry $341,990
Dr. David Spiegel, M.d, M.D
Psychiatry — Payments: $40,937
Psychiatry $40,937
Charles Debattista, Md, MD
Psychiatry — Payments: $35,632
Psychiatry $35,632
Neir Eshel, Md, MD
Psychiatry — Payments: $20,083
Psychiatry $20,083
Rona Hu, Md, MD
Psychiatry — Payments: $16,336
Psychiatry $16,336
Dr. Jack Turban, Md, MD
Psychiatry — Payments: $15,000
Psychiatry $15,000